BRIEF

on Medacta Group SA (isin : CH0468525222)

Medacta Celebrates 25 Years with 10th M.O.R.E. International Symposium in Switzerland

Medacta Group SA has announced the celebration of its 25th anniversary and the hosting of the 10th M.O.R.E. International Symposium in Lugano, Switzerland. The event, set for April 15-19, 2024, will focus on the sustainability of personalized medicine and technology in orthopedics and spine surgery. More than 1,200 participants globally are expected to attend this milestone event, emphasizing Medacta's commitment to innovation in medical care.

Francesco Siccardi, CEO of Medacta, highlighted the significance of the symposium and the company's ongoing investments in its birthplace, Ticino, demonstrating its dedication to improving patient care worldwide. The symposium will involve a substantial investment, benefiting local businesses and showcasing Lugano's beauty with special events.

This year's symposium will explore advancements in personalized medicine, such as the NextAR platform, leveraging augmented reality and AI, and Kinematic Alignment techniques for knee surgery. Also, the symposium will cover the latest in minimally invasive techniques for hip surgery and progress in sports medicine and arthroscopy, showcasing Medacta’s comprehensive approach to orthopedic care and education.

The international gathering will feature over 160 expert speakers and aims to foster knowledge sharing among surgeons to enhance patient outcomes. Dr. Alberto Siccardi, President and founder of Medacta, reflects on the company's journey and the impact it has made on orthopedic care and community wellbeing through its Medacta for Life Foundation.

As Medacta marks its 25th year, the 10th M.O.R.E. International Symposium exemplifies its worldwide growth and continuous focus on innovation and medical education to improve patient well-being globally.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Medacta Group SA news